Definitions - WHO
1 Definitions • Pharmacovigilance • Adverse event • Adverse reaction – Unexpected adverse reaction – Serious adverse reaction • Side effect
Download Definitions - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Drug-Induced Hematologic Disorders Kamakshi V. …
www.mhpharmacotherapy.comDrug-Induced Hematologic Disorders Kamakshi V. Rao eCHAPTER ... 2
The use of the WHO-UMC system for standardised …
www.who.intThe use of the WHO-UMC system for standardised case causality assessment - 3 - have or any other drug taken. For ‘Probable’, on …
ABCDE SYSTEM (ADVERSE EVENTS OF TYPE A, B, C, …
www.blackwellpublishing.com1 A ABCDE SYSTEM (ADVERSE EVENTS OF TYPE A, B, C, D, E) HISTORY Hurwitz and Wade proposed many years ago four categories of adverse events (Br Med J …
DRAFT GUIDANCE FOR INDUSTRY ON REPORTING …
www.cdsco.nic.indraft guidelines on reporting serious adverse events dated:11-05-2011 page 1 of 9 guidelines on reporting serious adverse event draft guidance for industry on reporting serious adverse events
ADVERSE DRUG REACTION-CAUSALITY …
ijrpc.comIJRPC 2011, 1(3) Srinivasan et al. ISSN: 2231 2781 606 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com ADVERSE DRUG REACTION-CAUSALITY ASSESSMENT
CLINICAL SAFETY DATA MANAGEMENT …
www.ich.orgClinical Safety Data Management The following definitions, with input from the WHO Collaborative Centre, have been agreed: 1. Adverse Event (or Adverse Experience)
Adverse Event Report Form and Guidelines For …
www.crp.mcgill.caPage 1 of 14 15-Apr-2009 Adverse Event Report Form and Guidelines For Clinical Studies The Adverse Event Report (AER) form is used to collect initial and follow-up
SUSPECTED ADVERSE DRUG REACTION …
www.cdsco.nic.inSUSPECTED ADVERSE DRUG REACTION REPORTING FORM For VOLUNTARY reporting of Adverse Drug Reactions by healthcare professionals CDSCO Central Drugs Standard Control ...
Related search queries
Drug-Induced Hematologic Disorders, System for standardised case causality assessment, Drug, ABCDE SYSTEM ADVERSE EVENTS OF TYPE, Adverse, Draft guidance for industry on reporting, ADVERSE DRUG REACTION-CAUSALITY, ADVERSE DRUG REACTION-CAUSALITY ASSESSMENT, Clinical Safety Data Management, Adverse Event Report Form and Guidelines For, Adverse Event Report Form and Guidelines For Clinical Studies, SUSPECTED ADVERSE DRUG REACTION, SUSPECTED ADVERSE DRUG REACTION REPORTING FORM, Adverse Drug